Offer - Urjas Oil for just ₹ 1
Tesunate 50 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Malaria are some of its major therapeutic uses.
The correct dosage of Tesunate 50 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Tesunate 50 Mg Tablet also has some side effects, the most common being Headache, Nausea or vomiting. While these are the most often observed Tesunate 50 Mg Tablet side effects, there are can be others also. These have been listed below. These side effects of Tesunate 50 Mg Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Tesunate 50 Mg Tablet's effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Tesunate 50 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Tesunate 50 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tesunate 50 Mg Tablet in conditions like Drug Allergy. Other conditions have been mentioned below in the Tesunate 50 Mg Tablet contraindications section.
Drug interactions for Tesunate 50 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Tesunate 50 Mg Tablet is not safe while driving, and is is not addictive in nature.
Tesunate 50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tesunate 50 Mg Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Tesunate. It is best to stop taking Tesunate immediately and inform your doctor if you notice any discomfort.
Is the use of Tesunate 50 Mg Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Tesunate. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Tesunate 50 Mg Tablet on the Kidneys?
In the absence of any research, there are no known side effects of Tesunate on kidneys.
What is the effect of Tesunate 50 Mg Tablet on the Liver?
Tesunate may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tesunate 50 Mg Tablet on the Heart?
Tesunate may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Tesunate 50 Mg Tablet unless your doctor advises you to do so -
Is this Tesunate 50 Mg Tablet habit forming or addictive?
Tesunate 50 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Tesunate 50 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Tesunate 50 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Tesunate 50 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Tesunate 50 Mg Tablet
Taking Tesunate 50 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Tesunate 50 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Tesunate 50 Mg Tablet with alcohol will be.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 830